We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Future of Genomic Sciences May Be Large-Scale Sequencing

By LabMedica International staff writers
Posted on 08 Jan 2010
Scientists are gaining insights into new ways to utilize microorganisms in medicine and manufacturing through a coordinated large-scale effort to sequence the genomes of not just individual microorganisms but entire ecosystems, according to a new report that outlines recommendations for this massive effort. More...


The report, from the American Academy of Microbiology (Washington, DC, USA), is based on a colloquium convened by the Academy in September 2008. The report outlines recommendations for large-scale microbial sequencing efforts directed toward cultivated isolates and single cells, as well as a community-scale approach to characterize a set of defined ecosystems of varying complexity.

Until recently, sequencing entire microbial genomes was laborious and costly, and the decision to sequence the genome of an organism was made by researchers or funding agencies. This ad hoc approach to collecting sequence data has resulted in an unbalanced and highly biased sampling of microbial diversity. Now, due to new technologies, the cost and effort of sequencing is within reach for even the smallest labs, and the ability to sequence the genomes of a significant fraction of microbial life may be possible. Systematic genomics efforts, such as the ones outlined in the report, would considerably broaden scientists' view of biologic diversity and have significant effects on science.

"A consensus rapidly emerged during the meeting that a taxonomically driven approach to gathering microbial genome information will provide the greatest impact on our view of microbial diversity, the potential to find novel genes and proteins, and our understanding of the complexity of the microbial consortia that maintain the health of this planet,” remarked Margaret Riley, Ph.D., colloquium chair.

The report outlined a five-pronged, coordinated initiative to comprehensively describe six different microbial ecosystems, designed to illustrate all the gene diversity across genomes. In this effort, the report noted that sequencing should be complemented by other experimental data, particularly transciptomics and metabolomics data, all of which should be gathered and curated continuously.

"Systematic genomics efforts like the ones outlined in this document would significantly broaden our view of biological diversity and have major effects on science,” stated Dr. Riley.

A full copy of the report and further recommendations can be found on the Academy website given below.

Related Links:

American Academy of Microbiology
Academy report and recommendations




Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Pipette Controller
Sapphire MaxiPette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.